A comprehensive view of hepatitis C management and the goal of eradication

Authors

DOI:

https://doi.org/10.59093/27112330.114

Keywords:

hepatitis C, direct-acting antivirals.

Abstract

Hepatitis C is a viral disease caused by the hepatitis C virus (HCV), which was first identified in 1989 by a team of scientists led by Michael Houghton at Chiron Corporation. This form of hepatitis was known as "non-A non-B hepatitis" as the infectious agent responsible couldn't be identified. It can affect individuals of different genders and sexual orientations, including men who have sex with men (MSM); transmission occurs through situations involving blood exchange, such as needle sharing or equipment for drug injection, or during sexual practices that may cause microlesions in the anal mucosa. It's important to note that hepatitis C can also be transmitted through other routes, such as unsafe blood transfusion, exposure to contaminated medical instruments, or sharing personal items that may have infected blood.

Downloads

Download data is not yet available.

Author Biography

Juan Carlos Restrepo-Gutiérrez, Hospital Pablo Tobón Uribe, Universidad de Antioquia

Médico, Especialista en Medicina Interna, Especialista en Hepatología Clínica, MSc, PhD. Profesor Titular, Facultad de Medicina, Universidad de Antioquia. Jefe Sección Gastrohepatología, Coordinador Especialización en Hepatología Clínica, Grupo Gastrohepatología, Universidad de Antioquia. Coordinador Unidad de Hepatología y Programa de Trasplante de Hígado, Hospital Pablo Tobón Uribe, Universidad de Antioquia. Medellín, Colombia.

References

Campollo O, Amaya G, McCormick PA. Milestones in the discovery of hepatitis C. World J Gastroenterol 2022;28:5395-5402. https://doi.org/10.3748/wjg.v28.i37.5395.

Nijmeijer BM, Koopsen J, Schinkel J, Prins M, Geijtenbeek TB. Sexually transmitted hepatitis C virus infections: Current trends, and recent advances in understanding the spread in men who have sex with men. J Int AIDS Soc 2019;22:e25348. https://doi.org/10.1002/jia2.25348.

Liu CH, Kao JH. Acute hepatitis C virus infection: Clinical update and remaining challenges. Clin Mol Hepatol 2023;29:623-642. https://doi.org/10.3350/cmh.2022.0349.

Lynch EN, Russo FP. Outcomes and follow-up after hepatitis C eradication with direct-acting antivirals. J Clin Med 2023;12:2195. https://doi.org/10.3390/jcm12062195.

Martinello M, Naggie S, Rockstroh JK, Matthews GV. Direct-acting antiviral therapy for treatment of acute and recent hepatitis C virus infection: A narrative review. Clin Infect Dis 2023;77:S238-S244. https://doi.org/10.1093/cid/ciad344.

Daw MA, El-Bouzedi AA, Ahmed MO, Dau AA, Agnan MM, Drah AM. Geographic integration of hepatitis C virus: A global threat. World J Virol 2016;5:170-182. https://doi.org/10.5501/wjv.v5.i4.170.

Parums DV. Effective direct-acting antiviral treatments support global and national programs to eliminate hepatitis C. Med Sci Monit 2023;29:e940519. https://doi.org/10.12659/MSM.940519.

Marín-Zuluaga JI, Díaz-Ramírez GS. Tratamiento actual de la hepatitis C en Colombia. Hepatología 2020;1:99-115. https://doi.org/10.52784/27112330.119.

Downloads

Published

2024-05-02

How to Cite

Restrepo-Gutiérrez, J. C. (2024). A comprehensive view of hepatitis C management and the goal of eradication. Hepatología, 5(2), 120–122. https://doi.org/10.59093/27112330.114

Issue

Vol. 5 No. 2 (2024): May-August

Section

Editorial

License

Copyright (c) 2024 Hepatología

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

La política de reconocimiento de autoría de Hepatología se basa en los criterios indicados por el ICMJE para conferir crédito de un trabajo a una persona, a la vez que se le atribuye responsabilidad por la publicación del mismo.

QR Code
Crossref Cited-by logo
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views

Some similar items: